SCHEMBL2962267

SCHEMBL2962267

CC1C=C(c2ccccc2)c2ccc(Br)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.38
ALDH1A1 P00352 3/20 0.38
GABRA1 P14867 2/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37
GABRA2 P47869 2/20 0.37
GABRB2 P47870 2/20 0.37
PTPRC P08575 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP19A1 P11511 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
NPC1 O15118 1/20 0.33
TSHR P16473 1/20 0.33
RAB9A P51151 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
DCLK1 O15075 1/20 0.33
PRKD3 O94806 1/20 0.33
MAP4K4 O95819 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2973762 0.86 MAPK1 (0.40) MAPK1ALDH1A1GABRA1GABRA5GABRA3
SCHEMBL2964022 0.85 ALDH1A1 (0.39) MAPK1ALDH1A1NPC1RAB9AHTR2A
SCHEMBL6627745 0.80 ALDH1A1 (0.37) MAPK1ALDH1A1PTPRCCYP2A6HPGD
SCHEMBL2972714 0.79 CYP1A2 (0.35) MAPK1ALDH1A1PTPRCCYP1A2SLC6A2
SCHEMBL2966313 0.76 MAPK1 (0.33) MAPK1ALDH1A1PTPRCCYP1A2SLC6A2
SCHEMBL2973795 0.76 ALDH1A1 (0.32) MAPK1ALDH1A1GABRA1GABRA5GABRA3
SCHEMBL2970027 0.76 NPC1 (0.43) MAPK1ALDH1A1NPC1TSHRRAB9A
SCHEMBL2958732 0.76 RAPGEF4 (0.33) PGR
SCHEMBL2970025 0.74 TP53 (0.35) ALDH1A1SLC6A2SLC6A4SLC6A3NPC1
SCHEMBL2974937 0.74 PGR (0.40) MAPK1ALDH1A1PTPRCCYP1A2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 MAPK1 3118/4885ALDH1A1 4332/4885GABRA1 3234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.